Federal cannabis policy is moving the industry's way for the first time in decades, but the reform has landed unevenly: state-licensed medical cannabis reached Schedule III in April 2026 while adult-use — the majority of MSO revenue — remains Schedule I pending a DEA hearing whose record closes July 15, 2026, leaving the industry's 280E tax relief, and its most levered balance sheets, hostage to a process that could still stall or be clawed back.
📈 What changed: July 15, 2026: The DEA's expedited administrative hearing on extending Schedule III to adult-use marijuana concluded on schedule after opening June 29; the administrative law judg…
| Indicator | Score | Reading |
|---|---|---|
| Maturity higher is better · high confidence | 69/100 | A $28-30B recurring US retail market sits on top of a legally bifurcated foundation: medical cannabis reached Schedule III in April 2026, adult-use has not. |
| Evidence Strength higher is better · high confidence | 85/100 | The load-bearing rescheduling fact is anchored directly in DOJ/DEA filings; corroboration across law-firm alerts and trade press is deep. |
| Commercial Proximity higher is better · high confidence | 59/100 | Recurring revenue exists at scale today, but growth is anaemic and the near-term tax wedge is only half-open. |
| Capital & Policy Support higher is better · low confidence | 36/100 | Genuine federal momentum for the first time in decades, but every major lever (full rescheduling, SAFE Banking) remains unresolved and contested. |
| Crowding Risk lower is better · medium confidence | 68/100 | Cannabis equities are re-rating sharply into the July 2026 DEA hearing, a classic pre-catalyst positioning build. |
| Reflexivity Risk lower is better · high confidence | 64/100 | Single policy headlines move this sector far more than any quarterly earnings print, and the weaker balance sheets are genuinely capital-markets dependent. |
Every indicator score is computed by the Northstar engine from analyst-set ordinal bands — never hand-written, never stored.
The public page is the summary (backed by 15 cited sources). Full briefing — company map, catalysts, native signals and sources — is inside the app.
Open in the appStart free →The Northstar Signal — what moved across all 350 themes and why, in your inbox. Free, no spam, one-click unsubscribe.